Gleason Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.09K | Hold |
6,000
| – | – | ﹤0.01% | 182 |
|
|
2025
Q1 | $5.47K | Hold |
6,000
| – | – | ﹤0.01% | 177 |
|
|
2024
Q4 | $6.54K | Hold |
6,000
| – | – | ﹤0.01% | 179 |
|
|
2024
Q3 | $4.54K | Hold |
6,000
| – | – | ﹤0.01% | 178 |
|
|
2024
Q2 | $7.44K | Hold |
6,000
| – | – | ﹤0.01% | 204 |
|
|
2024
Q1 | $11.3K | Hold |
6,000
| – | – | ﹤0.01% | 170 |
|
|
2023
Q4 | $15.8K | Hold |
6,000
| – | – | ﹤0.01% | 160 |
|
|
2023
Q3 | $13.8K | Hold |
6,000
| – | – | ﹤0.01% | 172 |
|
|
2023
Q2 | $21.9K | Buy |
+6,000
| New | +$21.9K | 0.01% | 148 |
|